Skip to Main Content

Advertisement

Skip Nav Destination

Abstract CT091: Safety and pharmacodynamic activity of MEDI9197, a TLR 7/8 agonist, administered intratumorally in subjects with solid tumors

Cancer Res (2017) 77 (13_Supplement): CT091.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Joshua D. Bernstock
  • Kyung-Don Kang
  • Neil V. Klinger
  • Hannah E. Olsen
  • Sam Gary
  • Stacie K. Totsch
  • Gelare Ghajar-Rahimi
  • David Segar
  • Eric M. Thompson
  • Victor Darley-Usmar
  • Bryan T. Mott
  • Luca Peruzzotti-Jametti
  • Gregory K. Friedman
Oncogene (2022) 41 (19): 2663.
  • Sachin Bhagchandani
  • Jeremiah A. Johnson
  • Darrell J. Irvine
Advanced Drug Delivery Reviews (2021) 175: 113803.
  • Farrukh Vohidov
  • Lauren E. Milling
  • Qixian Chen
  • Wenxu Zhang
  • Sachin Bhagchandani
  • Hung V.-T. Nguyen
  • Darrell J. Irvine
  • Jeremiah A. Johnson
Chemical Science (2020) 11 (23): 5974.
  • Ling Bai
  • Wenqian Li
  • Weijia Zheng
  • Dongsheng Xu
  • Naifei Chen
  • Jiuwei Cui
Pharmacological Research (2020) 159: 105017.
  • Mark Aleynick
  • Judit Svensson-Arvelund
  • Christopher R. Flowers
  • Aurélien Marabelle
  • Joshua D. Brody
Clinical Cancer Research (2019) 25 (21): 6283.
  • Alvaro H Ingles Garces
  • Lewis Au
  • Robert Mason
  • Jennifer Thomas
  • James Larkin
Expert Opinion on Investigational Drugs (2019) 28 (8): 695.
  • Audrey Simonaggio
  • Aurélien Marabelle
Bulletin du Cancer (2018) 105: S121.
  • Julian A. Marin-Acevedo
  • Aixa E. Soyano
  • Bhagirathbhai Dholaria
  • Keith L. Knutson
  • Yanyan Lou
Journal of Hematology & Oncology (2018) 11 (1)
  • Julian A. Marin-Acevedo
  • Bhagirathbhai Dholaria
  • Aixa E. Soyano
  • Keith L. Knutson
  • Saranya Chumsri
  • Yanyan Lou
Journal of Hematology & Oncology (2018) 11 (1)
  • Robert W. Wilkinson
  • Andrew J. Leishman
Frontiers in Immunology (2018) 9
Close Modal

or Create an Account

Close Modal
Close Modal